Author:
Andersson Charlotte,Søgaard Peter,Hoffmann Søren,Hansen Peter R,Vaag Allan,Major-Pedersen Atheline,Hansen Thomas Fritz,Bech Jan,Køber Lars,Torp-Pedersen Christian,Gislason Gunnar H
Abstract
ObjectiveTo examine the association between selected glucose-lowering medications and left ventricular (LV) diastolic function in patients with diabetes.DesignRetrospective cohort study (years 2005–2008).MethodsEchocardiograms of 242 patients with diabetes undergoing coronary angiography were analyzed. All patients had an LV ejection fraction (LVEF) ≥20% and were without atrial fibrillation, bundle branch block, valvular disease, or cardiac pacemaker. Patients were grouped according to the use of metformin (n=56), sulfonylureas (n=43), insulin (n=61), and combination treatment (n=82).ResultsMean age (66±10 years) and mean LVEF (45±11%) were similar across the groups. Mean isovolumic relaxation time (IVRT) was 66±31, 79±42, 69±23, and 66±29 ms in metformin, sulfonylureas, insulin, and combination treatment groups respectively (P=0.4). Mean early diastolic longitudinal tissue velocity (e′) was 5.3±1.6, 4.6±1.6, 5.3±1.8, and 5.4±1.7 cm/s in metformin, sulfonylureas, insulin, and combination treatment groups (P=0.04). In adjusted linear regression models, the use of metformin was associated with a shorter IVRT (parameter estimate −9.9 ms, P=0.049) and higher e′ (parameter estimate +0.52 cm/s, P=0.03), compared with no use of metformin. The effects of metformin were not altered by concomitant use of sulfonylureas or insulin (P for interactions >0.4).ConclusionsThe use of metformin is associated with improved LV relaxation, as compared with no use of metformin.
Subject
Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism
Cited by
33 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献